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Abbreviations 
  
AIDS Acquired immunodeficiency syndrome 
ATL Adult T-cell leukemia 
CE Capillary electrophoresis 
DIS Dimerization initiation site 
EMSA Electrophoretic mobility shift assays 
EPRS Glutamyl-prolyl-tRNA synthetase 
FA Fluorescence anisotropy 
GAIT Gamma-activated inhibitor of translation 
HAM/TSP HTLV-1 associated myelopathy/tropical spastic paraparesis 
HIV Human immunodeficiency virus 
HTLV Human T-cell lymphotropic virus 
LysRS Lysyl-tRNA synthetase 
MW Molecular weight 
NMIA N-methylisatoic anhydride 
NMR Nuclear magnetic resonance 
PAGE Polyacrylamide gel electrophoresis 
PBS Primer binding site 
PDDF Pair-distance distribution functions 
ProRS Prolyl-tRNA synthetase 
RNase Ribonuclease 
RSV Rous sarcoma virus 
RT Reverse transcription 
SAXS Small-angle X-ray scattering 
SEC Size exclusion chromatography 
SHAPE Selective 2’-hydroxyl acylation analyzed by primer extension 
SIV Simian immunodeficiency virus 
TAR Trans activating response 
TLE tRNA-like element 
WHO World Health Organization 
WT Wild type 
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Introduction 
Retroviruses are a diverse family of viruses with members that affect nearly all vertebrates, and 
many of them carry oncogenes that cause cancerous growth in their host organisms. Since the discovery 
of the first human retrovirus in a patient with a cutaneous T-cell lymphoma in 1979 (Gallo, 2005), 
retroviruses have been found to be the cause of devastating diseases including acquired 
immunodeficiency syndrome (AIDS) and adult T-cell leukemia (ATL) that affect millions of people 
worldwide.  Many of these diseases still have no treatment, and none have been cured.   
The retroviridae family is divided into seven different genera, three of which contain viruses that 
infect humans: lentiviruses, deltaretroviruses, and spumaviruses.  However, the only spumavirus to be 
isolated from humans, prototype foamy virus, is non-transmissible and nonpathogenic in humans 
(reviewed by Meiering et al., 2001).  Although most retroviruses from the other two genera are 
transmissible from human to human, the majority of them are not known to be pathogenic.  In fact, the 
only two retroviruses that have been shown to cause human disease are human immunodeficiency virus 
(HIV), and human T-cell lymphotropic virus type 1 (HTLV-1)—the viruses that cause the diseases 
mentioned above and are consequently the topic of this thesis.   
Retroviridae differs from many other viral families due to two major lifecycle events: reverse 
transcription (RT) and integration (Figure 1).  During RT, the viral RNA genome is copied from ssRNA to 
dsDNA after which it can be imported into the nucleus to undergo integration into the host cell’s genome. 
For RT to initiate, a primer must specifically anneal to the primer binding site (PBS) in the 5′ untranslated 
region (5′UTR) of the retroviral genome.  All retroviruses and long terminal repeat retrotransposons use 
host cell tRNAs as the primer for reverse transcription (Marquet et al., 1995; Mak et al., 1997), including 
the two viruses of interest: HIV-1 uses tRNALys3, and HTLV-1 uses tRNAPro. All three human tRNALys 
isoacceptors along with human lysyl-tRNA synthetase (LysRS) are selectively packaged into HIV-1 particles 
(Jiang et al., 1993).   Our lab has demonstrated that human LysRS facilitates priming in HIV-1 by binding a 
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tRNA-like-element (TLE) near the PBS, localizing the tRNALys3 primer (Jones et al., 2013; Jones & Cantara 
et al., 2014).  As the primer for HTLV-1 RT is tRNAPro, we hypothesized that this virus could employ a similar 
mechanism involving human glutamyl-prolyl-tRNA synthetase (EPRS) binding to a TLE. 
The lifecycle of a retrovirus is highly complex, and the 5′UTR is at the center of more than just 
primer localization (Figure 1).  Therefore, although we are particularly interested in the details of how 
aminoacyl-tRNA synthetases are potentially involved in packaging the primer that is required for RT, we 
are also interested in the structure and function of this large RNA as a whole.   In this thesis, I will discuss 
improvements made to the analysis of RNA probing data, experiments performed to study the structure 
and function of the HIV-1 5′UTR, and investigations of the putative interaction between elements within 
the HTLV-1 5′UTR and EPRS. Using a wide variety of biochemical techniques, we hope to elucidate 
information about these viral processes that could eventually aid in the production of therapeutic agents.  
 
Figure 1: The retroviral life cycle (modified from Dr. Tiffiny Rye-McCurdy). RT and integration can be seen in steps 
2 and 4 of the viral lifecycle.  The packaging of the tRNA primer and aminoacyl tRNA synthetase are shown in the 
red dashed box.  Steps of the viral lifecycle that directly involve the 5′UTR in the viral RNA or proviral DNA are 
marked by a red “*”.   
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Chapter 1: RNA Probing Data Analysis Method 
Introduction 
 In addition to serving as a key player in translation of the genetic code, RNA is capable of having 
many regulatory and enzymatic functions as well.  As with proteins, these functions are directly related to 
the three dimensional (3D) shape, or tertiary structure, of the RNA molecule. However, crucial to 
understanding the 3D structure and function of an RNA is knowledge of the base-pairing interactions, or 
secondary structure, of the molecule.  In conjunction with informing the tertiary structure, the secondary 
structure can aid in the search for familiar RNA functional motifs and facilitate the design of RNA 
constructs that are likely to maintain their native fold.   However, the current RNA secondary structure-
prediction algorithms are not usually sufficient for determining the fold of large RNA molecules, such as 
retroviral genomes, because they are unable to distinguish between structures with similar free energies 
(Rice et al., 2014).  Furthermore, traditional structural techniques such as X-ray crystallography and NMR 
often fall short as well, due to the flexibility of many RNA molecules in solution and their slow rate of 
rotation in solution (Cantara & Olson et al., 2014).  Therefore, using chemical and enzymatic agents to 
probe the structures of these molecules is essential to obtaining accurate structures of most RNAs (Figure 
2A) (Weeks, 2010).  Additionally, these techniques can be useful in studying RNA-protein complexes, as 
they can be used to interrogate the location of protein binding to the RNA molecule, as well as any 
secondary structural changes this binding confers to the RNA (Figure 2B) (Xu et al., 2009).   
 There are a large number of RNA probing methods, but two will be the focus of the current 
chapter: ribonuclease (RNase) digestion and selective 2′ hydroxyl acylation analyzed by primer extension 
(SHAPE)—each with its own set of benefits and drawbacks.  RNase digestion involves reacting RNAs with 
enzymes that cleave the RNA backbone with specific nucleotide and base-pairing preferences. From 
analysis of the digestion pattern, whether a nucleotide is in a single- or double-stranded region can be 
determined.  Although primer extension is not required for the analysis of RNase digestion experiments, 
it can be a useful tactic; since the resulting cDNA is much more stable than the initial RNA, it improves the 
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analysis of longer RNAs, and it allows these reactions to be analyzed in a high-throughput manner. RNase 
digestion can be advantageous for multiple reasons: (1) it is a robust enzymatic reaction, (2) it is one of 
the simplest probing reactions that is capable of resolution in double-stranded regions of RNA, and (3) 
RNases are sterically large agents that can be useful for RNA-protein footprinting. However, due to 
enzyme specificities, multiple enzymes are required to obtain resolution throughout the RNA, making this 
potentially more labor intensive than other methods.  SHAPE on the other hand, uses reactive anhydrides 
 
Figure 2: Experimental schematic for RNA structure probing (A) and RNA-Protein footprinting (B).  For either 
technique RNAs are subjected to reactions with enzymes or chemical probes that result in cleavages to the RNA 
backbone or covalent modifications.  The resulting RNA from the reactions is then denatured, and 5’end-labeled 
primers are annealed for detection after reverse transcription.  During primer extension, reverse transcriptase 
will not be able to extend past cleavages or modifications resulting in cDNA of varying lengths. (C) Primer 
extension products can be analyzed by either PAGE (left) or CE (right).  “Seq.” stands for sequencing, “P” stands 
for protection, “(+)” represents the reaction, and “(-)” represents the background.   
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to selectively acylate the 2′ hydroxyl group in the ribose sugar of the RNA backbone.  The kinetics of this 
reaction are dependent on the flexibility of the RNA at each nucleotide (Merino et al., 2005).  Thus, as 
single-stranded RNA is much more flexible, these nucleotides will also be the most reactive to SHAPE 
reagents.  During primer extension, reverse transcriptase cannot move past the SHAPE-modified sugar in 
the RNA backbone, allowing for the quantification of the reactivity at each nucleotide (Merino et al., 
2005).  The major advantage of SHAPE is that it is capable of detecting nearly every single-stranded and/or 
flexible nucleotide, making it extremely useful for structure probing.  Conversely, low reactivity at base-
paired nucleotides makes SHAPE less useful for RNA-protein footprinting.  There are also many other RNA 
probing techniques involving base-specific chemical reactions, or hydroxyl radical footprinting (reviewed 
in Weeks, 2010); however, these will not be discussed here.   
 After the reactions and primer extensions are complete there are also three different methods of 
analyzing the results: (1) urea polyacrylamide gel electrophoresis (PAGE), (2) capillary electrophoresis 
(CE), and (3) next generation sequencing.  Both CE and next generation sequencing are considered high-
throughput, meaning they allow for many more experiments to be more accurately and easily quantified 
than PAGE.  Next generation sequencing is much less cost effective than CE, so our efforts were focused 
on CE.   CE data can be difficult to interpret when trying to optimize techniques.  Therefore, the first 
section of this chapter will demonstrate how PAGE analysis was used to optimize RNA probing and 
sequencing experiments, leading to the qualitative analysis of CE data.  
The data CE produces must be heavily processed before they can be accurately analyzed, and this 
processing of high-throughput RNA probing is what we are interested in improving.  There are currently a 
few programs that exist that facilitate CE data analysis: SHAPEfinder (Vasa et al., 2008), QuShape 
(Karabiber et al., 2013), and FAST (Pang et al., 2011).  However, each of these has disadvantages.  None 
of these programs are transparent, meaning they don′t allow you to see and change the calculations that 
the program is performing.  Second, all three of these are relatively slow, frequently make errors, and do 
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not possess easy controls for correcting these errors.  The second section of this chapter will present our 
modifications to the methods that are used in the currently accepted programs; it will also introduce the 
transparent tool that we have developed in order to facilitate our calculations.  This method is pending 
validation by reproducing the previously determined secondary structure of the HIV-1 5′UTR. 
 
Materials and Methods 
RNA preparation 
 The 105 nt HIV-1 PBS/TLE RNA (Jones et al., 2013) was used for all RNA probing optimization 
experiments analyzed by PAGE.  This RNA was previously cloned out of the HIV-1 5′UTR, and into a pUC19 
vector behind a T7 promoter (Jones et al, 2013).  The transcription template was obtained by digestion of 
the plasmid with FokI restriction endonuclease. FokI was chosen because its cut site is distant from its 
recognition site, so it does not restrict the sequences that can be chosen for the 3′ end of the RNA 
construct (Hiroyuki et al., 1981).  
Three RNA constructs were analyzed in SHAPE/CE experiments—HIV-1 5′UTR(356) WT, HIV-1 
5′UTR(356) ∆DIS, and HIV-1 5′UTR(356) ∆DIS A34U.  The HIV-1 5′UTR(356) wild type (WT) construct 
contains the first 356 nucleotides of the NL4-3 isolate. The ∆DIS mutation was previously created from 
the pHIV-1 5′UTR(356) WT plasmid by mutating the dimerization initiation site (DIS) loop to a stable GAGA 
tetraloop (E. Olson, unpublished data).  The A34U mutation was also previously created from the pHIV 
5′UTR(356) ∆DIS plasmid by mutating A34 to T in the trans activating response element (TAR). Both the 
A34T and ∆DIS mutations prevent genomic dimerization and facilitate homogeneous RNA preparation 
(Helga-Maria et al., 1999; Skripkin et al., 1994).  These plasmids were then digested with FokI to create 
the transcription template.  
After obtaining transcription templates, RNAs were prepared via in vitro transcription with T7 RNA 
polymerase (Milligan et al. 1987), and analyzed for homogeneity using 8M urea (denaturing) PAGE.  
Desired bands were excised, crushed, and soaked in RNA elution buffer (0.5 mM NH4OAc, 1 mM EDTA) 
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overnight in a 37°C shaker.  The supernatant was then butanol extracted and ethanol precipitated to yield 
a pellet of purified RNA.  RNAs were folded in 50 mM HEPES (pH 7.4) buffer by heating at 80°C for 2 
minutes, cooling to 60°C for 2 minutes, adding 1 M MgCl2 to a final concentration of 10 mM, and (if longer 
than ~150 nt) incubating at 37°C. The three HIV-1 5′UTR(356) RNA constructs were optimized for folding 
homogeneity by varying the 37°C incubation time.  
5′ fluorescently labeling reverse transcription primer 
 To analyze RNA probing via CE, primers need to be labeled with particular fluorophores that can 
be detected.  Primers for reverse transcription and cycle sequencing 5’-end labeled with NED® dye were 
ordered from IDT. 
5′ 32P-labeling reverse transcription primer 
 Reverse transcription and sequencing primers for the PBS/TLE were 5′-end labeled with 32P using 
T4 polynucleotide kinase (PNK) and γ-32P ATP.  Reactions were incubated for 1 h at 37°C and then gel 
purified by denaturing PAGE.  Bands were excised, crushed and soaked in elution buffer at room 
temperature overnight.  The supernatant was then ethanol precipitated to yield pure 32P-labeled primers. 
These were then quantified using a liquid scintillation counter. 
Sequencing 
 Sequencing was performed using the Thermo Sequenase Cycle Sequencing kit (Affymetrix), a 
Sanger style sequencing kit utilizing dideoxynucleotides (ddNTPs).  NED- or 32P-labeled primers were 
designed to anneal to the part of the plasmid corresponding to the 3′ end of the RNA.  Primer extension 
was performed in the presence of one of the four ddNTPs, resulting in the termination of primer extension 
with every ddNTP addition.  These sequencing reactions were then analyzed by PAGE and CE to provide a 
ladder that can be aligned with the probing data. 
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SHAPE experiments 
 Two different SHAPE reagents were used in this study: N-methylisatoic anhydride (NMIA) (Sigma-
Aldrich) and 1-methyl-6-nitroisatoic anhydride (1M6) (Sigma-Aldrich).  NMIA reacts slowly, and is useful 
for characterizing nucleotides that exhibit slow dynamics (Rice et al., 2014). In contrast, 1M6 reacts more 
rapidly and also deactivates with water much quicker making it more useful for examining nucleotides 
with faster dynamics (Rice et al., 2014).  Prior to experimental data collection, RNA reactions were time 
optimized with SHAPE reagents to ensure single-hit kinetics were obtained.  SHAPE experiments were 
performed with a plus reaction (with SHAPE reagent) and a minus reaction (without SHAPE reagent) to 
control for background effects such as spontaneous reverse transcription termination.  Reactions were 
initiated with the addition of 1 µL of 80 mM SHAPE reagent to the plus reaction and 1 µL DMSO to the 
minus reaction, each tube containing approximately 8 pmols of RNA in 9 µL buffer (final reaction volume 
of 10 µL).  Reactions were then incubated at room temperature for the optimized time duration (22 min. 
for NMIA, and 3 min. for 1M6).  Reactions were then quenched by ethanol precipitation.  RNA pellets were 
resuspended and reverse transcribed with NED-labeled primers using Superscript III reverse transcriptase 
by following the manufacturer’s suggested protocol (Invitrogen).   
Ribonuclease optimization experiments analyzed via PAGE 
 Optimization of RNase T1 (which cleaves at single stranded guanosine residues) digestion 
conditions was performed on the HIV-1 PBS/TLE RNA using three different reactions: structured probing, 
unstructured probing, and alkaline hydrolysis.  Structured probing was carried out by the addition of 
RNase T1 to folded RNA followed by incubation at room temperature for 15 minutes.  The reactions were 
then quenched with precipitation/inactivation buffer (Ambion), and RNA pellets were reverse transcribed 
with 32P-labeled primers using Superscript III (Invitrogen).  The goal of this reaction is to determine which 
G residues are single stranded.  For unstructured probing, RNAs were heated to 50°C for 5 min to unfold 
them prior to addition of RNase T1. The remaining steps were carried out identically to structured probing.  
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The goal of this reaction is to provide a ladder of all of the G residues in the RNA.  Alkaline hydrolysis was 
performed by incubation of RNA at 95°C in alkaline hydrolysis buffer (Ambion).  Reactions were then 
quenched and carried out identically to the other two reactions.  The goal of this reaction is to provide a 
ladder of every nucleotide of the RNA.  Structured and unstructured reactions were optimized by the 
addition of varying amounts of RNase T1 (0.001 to 0.1 units/µL) and alkaline hydrolysis was optimized for 
incubation time (5 to 15 min).  These experiments were analyzed by denaturing PAGE and 
phosphorimaging of the gel. 
Ribonuclease digestion experiments analyzed via CE 
 Two RNases with different strand specificities and base preferences were used the RNA: RNase 
T1 and RNase V1.  These RNases prefer single-stranded guanosines and double-stranded nucleotides 
respectively.  All experimental data were collected with a plus and a minus reaction.  To initiate the 
reaction, RNases were added to folded RNAs in the plus tube and buffer was added to the minus.  They 
were then incubated at room temperature for 20 min and quenched by precipitating the RNA with 
premixed precipitation/inactivation buffer (Ambion).  RNA pellets were resuspended and reverse 
transcribed with NED-labeled primers using Superscript III.  
 
Results and Discussion 
Section I: RNA probing with RNases and SHAPE 
 RNA probing experiments are capable of providing secondary structure information at single-
nucleotide resolution.  However, these experiments can be complex, requiring optimization of several 
steps before the results can be accurately analyzed: such as folding conditions, reaction times, primer 
extension reactions, and sequencing.  The probing reaction needs to be optimized to obtain single-hit 
kinetics.  Failure to do so will result in a bias toward reactivity closer to the 3′ end of the RNA as reverse 
transcriptase will halt at the first cleavage/modification that it encounters.  Additionally, the quantity of 
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primer extension product and 
sequencing product that are 
optimal for analysis must be 
determined.  The remainder of this 
section will focus on description of 
how RNase digestion, primer 
extension, and sequencing 
experiments were optimized using 
PAGE, and how a new tool was 
developed to facilitate quicker and 
more user-friendly analysis of the 
CE data. 
 RNase optimization 
experiments (see Methods and 
Materials for detailed protocol) 
were chosen for initial experiments in our lab because they involve simple enzymatic reactions that can 
be analyzed both directly via denaturing PAGE and using primer extension analyzed by CE.  After initial 
control experiments to ensure proper function of the RNase and polymerase enzymes, experiments were 
undertaken to optimize the experimental concentration of RNase T1 (Figure 3).  These experiments also 
served to validate our reaction, primer extension, and sequencing conditions by demonstrating the 
correct digestion pattern of the HIV-1 PBS/TLE RNA.  Despite this success, further PAGE-analyzed 
experiments were not continued due to their many limitations.  First, the window of analyzable data on a 
sequencing PAGE gel is very small, limiting experiments to small RNAs unless many reverse transcription 
primers are used.  Second, sequencing PAGE gels are very delicate and are frequently damaged while 
 
Figure 3: RNase digestion experiment for 
optimization of various aspects of RNA probing 
using the HIV-1 PBS/TLE RNA, RNase T1, and 
PAGE analysis.  The left four lanes correspond 
to the four nucleotides of sequencing, and the 
next four lanes consist of an undigested control 
and folded RNA digested with varying 
concentrations of RNase T1.  The next three 
lanes are another undigested control and 
unfolded RNA digested with varying 
concentrations of RNase T1.  The right three 
lanes show three different incubation times of 
alkaline hydrolysis. RNase T1 cleaves at single-
stranded guanosines. The cleavage map above 
shows agreement with the accepted secondary 
structure of this RNA. 
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fixing or drying, resulting in loss of data.  Finally, these experiments require the use of radioactivity, 
necessitating extra safety precautions during experimentation.  For these reasons, we proceeded to 
analyze experiments via CE.   
  The RNase digestion experimental method was simplified significantly when translated to CE 
analysis.  Experiments involving RNase reactions with the unfolded RNA were eliminated due to the 
inclusion of the much more reliable sequencing lane.  During reverse transcription, a small fraction of the 
polymerase population will spontaneously terminate at each nucleotide.  While the resulting fragments 
from these terminations are difficult to detect via PAGE, they can be easily resolved using CE.  As a result, 
the single-nucleotide ladder provided by alkaline hydrolysis was redundant and removed from the 
protocol as well.  Therefore, RNase experiments analyzed by CE involved three types of samples: RNase 
digestions, background (no RNase), and sequencing.   
Additionally, it is possible to resolve much larger RNAs using CE than PAGE, so full-length 5’UTR 
constructs were used in these experiments.  Homogeneity of these constructs was tested using native 
PAGE (see materials and methods for detailed protocol).  It was found that the HIV-1 5’UTR(356) ∆DIS 
A34U construct was the most homogenous (Figure 4).  As a result, this RNA was selected for use in RNA 
probing experiments analyzed by CE.   
SHAPE probing was also optimized with the HIV-1 5′UTR(356) ∆DIS A34U.  Single-hit kinetics were 
optimized by testing multiple incubation times for two reagents, 1M6 and NMIA.  Single-hit kinetics are 
necessary because reverse 
transcriptase will always 
terminate at the first 
modification that it 
encounters.  If there is more 
than one modification on a 
 
Figure 4: Three different HIV-1 5’UTR constructs were optimized for folding 
by varying the incubation time at 37°C and analyzed using native PAGE.  The 
5’UTR ∆DIS A34U incubated at 37°C for 30 min. was the most homogenous.   
 
Wild Type ΔDIS ΔDIS A34U
(min. @37⁰C)
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given RNA, only the first one will be detected 
resulting in a bias in reactivity toward the 3’ end. 
Therefore, the criteria for optimal incubation 
was the time that showed the lowest 3’-end bias.  
However, all of the incubation times tested gave 
relatively even distributions of highly reactive 
nucleotides and little to no bias toward the 3′ end 
was observed (Figure 5).  This was likely the 
result of water inactivation of the anhydride.  As 
a result, the shortest incubation times were 
chosen arbitrarily.  In subsequent experiments, both structure probing and protection, a high rate of 
spontaneous termination of reverse transcription was observed, resulting in low processivity of the 
polymerase and many negative reactivity values.  This may be due to the highly-structured nature of the 
HIV-1 5′UTR.  Experiments are in progress to test different thermo-denaturing cycles to improve reverse 
transcriptase processivity.   
  
Section II: RNA probing data analysis improvements  
There are three programs that are predominantly used for analysis of RNA probing data—two 
programs produced by the Weeks lab: SHAPEfinder (Vasa et al., 2008) and QuShape (Karabiber et al., 
2013), and a program produced by the Glenn lab called Fast (Pang et al., 2011).  There are also other, less 
commonly-used, programs that will not be discussed in detail.  Therefore, I will primarily focus on how 
our method addresses issues with FAST and QuShape.  Our analysis method can be divided into four major 
steps: signal alignment, preprocessing, sequence alignment, and reactivity calculation. Each of these steps 
consists of multiple calculations (Figure 6) and how they improve upon other programs will be discussed. 
 
Figure 5: HIV-1 5′UTR ∆DIS A34U RNA was optimized for 
single-hit kinetics with 1M6 and NMIA.  All incubation 
times for both reagents resulted in even distribution of 
highly reactive peaks, and no significant preference for 
the 3′ end of the RNA molecule. 
3 min 10 min 15 min
# Highly Reactive Peaks 31.0 26.0 24.0
% 3' Half 54.8% 50.0% 45.8%
% 5' Half 45.2% 50.0% 54.2%
Difference (3'-5') 9.7% 0.0% -8.3%
22 min 30 min 45 min
# Highly Reactive Peaks 23.0 31.0 34.0
% 3' Half 52.2% 48.4% 44.1%
% 5' Half 47.8% 51.6% 55.9%
Difference (3'-5') 4.3% -3.2% -11.8%
1M6 Optimization
NMIA Optimization
15 
 
 
 
Figure 6: The processing flow charts for QuShape, FAST, and our improved analysis method are depicted above.  
The red-dashed box indicates the processing steps that frequently require cumbersome manual override in 
QuShape.  The blue-dashed box indicates the processing steps of FAST that have little transparency due to their 
dependence on Peak Scanner.  The green dashed boxes indicate the primary calculations in our improved 
analysis method that address these issues. 
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There are three aspects of QuShape that we address with our method: signal alignment, sequence 
alignment, and user interface.  There are two calculations involved in the signal alignment step: mobility 
shift and capillary alignment.  QuShape requires experiments to be set up in a two capillary, two dye 
scheme: reactions and sequencing run in the same capillary with different dyes, and the (+) and (-) 
reactions in different capillaries (Karabiber et al., 2013).   The idea behind this is that both reaction and 
sequencing can be run in the same capillary and therefore migrate under the same conditions.  However, 
this is not exactly the case because the dye has an effect on the migration rate of the DNA fragment; thus, 
this setup requires a mobility-shift correction to account for different dye mobilities.  This does not 
significantly affect accuracy or analysis time, but is an aspect that can be eliminated by experimental set 
up.   Additionally, as QuShape does not utilize size standards, it uses a mathematically complex algorithm 
to align the electropherograms between capillaries using a similarity matrix (Karabiber et al., 2013).  This 
algorithm often misaligns CE traces requiring a time-consuming manual override.  Incorporating size 
standards into the experimental set up (discussed later in this section) makes signal alignment much 
simpler and more accurate.  
The sequence-alignment step in QuShape performs three processing steps simultaneously, peak 
picking, sequence alignment, and peak linking.  This step frequently does not pick peaks correctly leading 
to errors in sequence alignment and peak linking, and requiring a very time-consuming manual override.  
Improvements to the peak picking process (discussed later in this section) alleviate the need for much of 
the manual override in this step.  Finally, when manually overriding calculations, the user interface of 
QuShape is very difficult to control, as it requires the user to drag and drop assignments in the signal and 
sequence alignment steps as opposed to entering a corrected numerical value.  This often leads to 
inaccuracies and increased analysis time.  The manual overrides built into our analysis method are 
completely numerical.  All of the processing is performed in Microsoft Excel™, which significantly improves 
the efficiency and control of these necessary overrides. 
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The main aspect of FAST that needs to be addressed is the lack of calculation transparency, as it 
depends on Peak Scanner (Applied Biosciences) for much of the data processing.  Five out nine calculations 
in FAST depend on Peak Scanner.  However, it is possible for errors to occur during these steps, and Peak 
Scanner does not have the calculation transparency for the user to see and correct them.  To address this, 
the data after each calculation of our analysis method is completely visible, and many of the parameters 
for each of the calculations are adjustable.   
The first step in the improved analysis method is signal alignment.  However, how this analysis 
step is accomplished is 
dependent on the correct 
experimental setup.  We use 
a three capillary experiment, 
meaning the (+) reaction, (-) 
reaction, and sequencing are 
all run in different capillaries 
with the same primers 
labeled with the same dye.  
Included in each of the three 
capillaries are size standards (DNA oligonucleotides of known length) that allow the signals to be aligned 
to one another.  Setting up the experiment in this way eliminates the need for mobility shift correction, 
and provides a much simpler and less error prone mechanism for capillary alignment.  Mathematically, 
the capillaries are aligned by scaling the X-axis of each (Xo) to a nucleotide based X-axis (Xnt) by fitting a 
polynomial to the size standard data.  This can then predict the relationship between Xo and Xnt in all of 
the capillaries (Figure 7).  After the capillaries are aligned, the analysis window can be chosen by visually 
analyzing the quality of the data and choosing the upper and lower nucleotide bounds.   
 
Figure 7: A cubic polynomial can be fit to the relationship between the 
migration time and the length of each size standard.  Xo is the migration time 
of the size standard and Xnt is its length in nt.  M3, M2, M1, and B are constants 
that can be calculated from the fit.  This figure shows how the size standards 
of one capillary can be scaled to the nucleotide based x-axis.  This is used to 
scale the x-axes of the (+) reaction, (-) reaction, and sequencing traces. 
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After the capillaries are aligned, the data are subjected to three preprocessing steps prior to 
analysis: smoothing, baseline correction, and signal decay correction.  Smoothing is performed using a 
moving triangular average method with user defined window size as shown in equations 1 and 2: 
Si is the smoothed intensity at data point i, and Ri is the raw intensity at data point i.  This eliminates high-
frequency noise in the data (O’Haver, 2016) by performing a weighted average of each raw  data point 
with an adjustable number of the surrounding data points (window size). Any window size can be chosen, 
but window sizes of greater than 2 often result in a significant loss of information.  Although smoothing 
of any kind results in a small loss of information, it improves the effectiveness of peak picking.   
Baseline correction is accomplished by subtracting the minimum number within a surrounding 
window from a given data point as shown in equation 3: 
Bi is the baseline corrected intensity at data point i, Si is the smoothed intensity from the previous step, 
and w represents the window size of the baseline correction.  The primary reason for baseline correction 
is to eliminate baseline offset that occurs close to the primer extension initiation (Karabiber et al., 2013).  
This also results in a decrease in the overlap between peaks making peak picking and Gaussian fitting 
much simpler.   
The final preprocessing calculation is signal decay correction.  Reverse transcriptase is not 
completely processive, so there is a certain probability that it will spontaneously terminate at any 
nucleotide.  Therefore, a smaller population of reverse transcriptase reaches further nucleotides than 
closer ones causing the intensities to decay quasi-exponentially for longer fragments (Aviran et al., 2011).  
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Furthermore, the decay is not constant as it depends on the population of reverse transcriptase that stops 
at any given point.  To correct for this phenomena, we divide the intensity of every nucleotide by the sum 
of the intensities of all the nucleotides after nucleotide i.  This is the correction equation that QuShape 
employs, and can be seen in equation 4 and 5 (Karabiber et al., 2013):  
Pi is the probability that reverse transcriptase will terminate at nucleotide i.  Bi is the baseline corrected 
intensity from the previous step, and k represents the last nucleotide within our analysis window.  Finally, 
Elast is the estimated sum of the intensities beyond nucleotide k.  This estimation is calculated by 
programmatically varying the Elast value to minimize the difference between the sum of the Pi values for 
the first half of the trace, and the sum of the Pi values for the second half.   However, to use this equation 
before peak area approximation (both our method, and QuShape employ it this way), it must be assumed 
that applying the formula at every data point is comparable to applying it at every nucleotide.  
The peaks that represent individual nucleotides of the RNA molecule must now be identified in 
the preprocessed data and this is the point that requires the most user involvement.  The majority of the 
peaks are picked by an automated algorithm.  This algorithm temporarily plots enhanced data that is the 
preprocessed data with its second derivative subtracted from it.  This emphasizes the peaks tremendously, 
but leaves the x values the same (Figure 8A).  Furthermore, this helps to deconvolute peaks that appear 
as a shoulder of another peak (Figure 8B) making picking the peaks much clearer.  Local maxima are 
identified as peaks if both of the following criteria are true: EX > EX-1 > EX-2 > EX-3 > EX-4 > EX-5 and EX > EX+1 > 
EX+2 > EX+3 > EX+4 > EX+5; where EX is the enhanced data at a specific point on the X-axis.  The enhanced data 
is only used for peak identification. The X-axis values are correlated with the corresponding Y-axis value 
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from the preprocessed data for further analysis. After the peaks are picked they must be related to the 
sequence of the RNA molecule.  Sequence assignment is performed using nucleotide number rather than 
the letters of the sequence for simplicity of calculation.  Since the sequencing and the reactions are scaled 
to the same X-axis, sequence alignment can be performed by assigning a single peak in the sequencing to 
a single peak in the reactions.  All of the surrounding peaks are then assigned based on this one peak.  The 
limitation to assigning the sequence using this method is that the peak picking algorithm is not perfect for 
all data sets and can miss assign peaks.  Missing or extra peaks during peak picking will result in a cascade 
of nucleotides being one or more positions out of alignment.  For this reason, a peak picking check function 
was incorporated into the analysis 
tool to tell the user where peaks are 
likely to be incorrectly assigned.  
Furthermore, easy-to-use, 
numerically based manual overrides 
were incorporated to facilitate this 
process.  Data from multiple 
experiments were compared to 
ensure that the peak-picking 
algorithm was consistent between multiple replicates. 
The fourth and final step to processing CE data is reactivity calculation, which involves three 
computations: peak area determination, scaling, and normalization.  The peak areas are calculated using 
Gaussian deconvolution because there is often overlap between CE peaks.  However, if done inefficiently 
this process can require significant computational resources or a long calculation time.  It was determined 
that the most computationally-efficient method to fit Gaussians to the hundreds of peaks in CE traces is 
to use a moving optimization window that includes the peak that is being fit, and peaks that are 
 
Figure 8: (A) Subtracting the second derivative from the preprocessed 
data enhances the peaks while leaving the x values the same.  (B) The 
black-dashed box shows how this method improves the picking of 
shoulders.  E(x) is the enhanced data, P(x) is the preprocessed data, 
and P′′(x) is the second derivative of the preprocessed data.  
 
            (A)
(B)
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immediately before and after it.  There are three Gaussian parameters that are unique to each peak: 
position, sigma, and amplitude.  To find the best fit for a single peak, trial values for one of the three 
parameters are tested, and the trial values that give the lowest error when compared to the preprocessed 
data are chosen (Figure 9).  The window then moves one peak to the right, and repeats this process.  This 
is done in three waves of moving optimization: first to optimize the X-axis position of each peak, then the 
sigma values, and then the amplitude.  Once the peak areas are calculated, the (+) and (-) traces can be 
scaled to one another to correct for load error.  This is performed under the assumption that low-area 
peaks are indicative of reverse transcriptase spontaneous termination (i.e. we would expect them to be 
equivalent in area in both traces).  A 
scaling factor, α, can be calculated by 
dividing the average of the lowest 20% 
of (+) peaks by the average of the 
lowest 20% of (-) peaks.  The minus 
peaks are then scaled to the plus by 
multiplying them by α.  Finally, the 
normalized reactivity values for each 
nucleotide can be calculated.  First, the 
background is removed by subtracting 
the (-) peak areas from the 
corresponding (+) peak areas.  
Background subtracted areas are then 
normalized by dividing by the average 
of the top 10% of peak areas.  Outliers 
are excluded when determining the 
 
Figure 9: Gaussian fitting of Peak 2.  P is the position of the peak, σ 
is the width at half the height of the peak, and A is the amplitude 
of the Gaussian function.  yo is the preprocessed intensity value of 
the unfit data at point x, and y1, y2, and y3 are the intensity values 
of the Gaussian fits of peaks 1, 2, and 3 respectively at the same x 
value. This figure shows how to calculate the Fiterror for a trial P, σ, 
or A value for a single this peak.  Many trial values are tested for 
each of these three values, and the trial values for each that give 
the lowest Fiterror are elected to represent the Gaussian of this 
peak.     
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top 10% if they are greater than the first quartile plus 1.5 times the interquartile range.  However, no 
more than 10% of peaks can be excluded.  Normalizing in this way allows a value of 1.0 to represent the 
average value of a highly reactive nucleotide.   
Once reactivity values are determined, different replicates can be used to compare and correct 
for missing or extra nucleotides in one or more of the replicates.  These data can then be used as 
constraints in RNA structure prediction, or in the case of protection experiments, analyzed for the 
footprint of the RNA binding molecule. 
  
Conclusions and Future Directions 
 The process of optimizing RNA probing is well underway, the CE data analysis improvements have 
allowed us to predict the structure of the HTLV-1 5′UTR, a very long and complex RNA.  However, there is 
still much that remains to be done as far as optimization and analysis are concerned.  Primer extension 
needs to be further optimized to allow for the efficient analysis of HIV-1 RNA probing data.  This will allow 
probing of the HIV-1 5′UTR-LysRS interaction footprint.  Additionally, it will then be possible to collect HIV-
1 5′UTR SHAPE data that can be used as a validation of our new analysis method.   
 There are also many improvements that we still would like to make to the probing analysis tool 
to facilitate CE data analysis.  While none of the planned improvements will affect the current signal 
processing methods, they improve the user experience.  First, we would like to incorporate the ability to 
convert FSA files (the file format in which CE data is packaged) into text files that can be opened and easily 
manipulated.  It would then be easy to program the analysis tool to copy the data from the raw file into 
the analysis tool automatically.  Currently we use an outside program to convert the files and copy and 
paste the data manually.  We would also like to incorporate a size standard picking mechanism into the 
analysis tool.  Currently, Peak Scanner (Applied Biosystems) is employed to find the X-axis values of the 
size standard peaks, which are then copied into the program manually.   Thus, incorporating data 
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importation and size standard picking in these ways would eliminate the involvement of any external 
programs in CE data analysis.  These improvements are currently being implemented. 
Probing optimization and analysis improvements will hopefully help future members of our group 
and others study RNA structure and function through chemical and enzymatic probing.  The crowning 
achievement of probing experiments in our lab following the improved probing analysis method has been 
determining the HTLV-1 5′UTR secondary structure using SHAPE (data discussed in Chapter 3).  This has 
contributed significantly to the study of this virus in our lab and pioneered the way for further SHAPE 
experimentation.  After optimization of SHAPE on the HIV-1 5′UTR is complete, resolving this well-studied 
secondary structure will be used to validate our probing analysis method. 
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Chapter 2: Human Immunodeficiency Virus Type I  
Introduction 
HIV-1 is well known as the cause of acquired immunodeficiency syndrome (AIDS), which is 
characterized by the depletion of CD4+ helper T-cells resulting in opportunistic infections or cancers that 
ultimately lead to the death of the patient (Gallo et al., 2003).  HIV-1 can be transmitted by blood-to-blood 
contact with an infected person (Drucker et al., 2001), vertically from mother to child either in utero or 
through breast feeding (Peckham et al., 1995), or sexually in both heterosexual and homosexual 
relationships.  The 2014 World Health Organization (WHO) statistics estimate that 37 million people are 
infected with HIV, a global prevalence of 0.8% (4.5% in Africa).  Furthermore, they estimate that more 
than 34 million people have died of AIDS-related causes since the beginning of the epidemic (World Health 
Organization, 2015).  HIV-1 belongs to the genus lentivirus, which includes simian immunodeficiency virus 
(SIV), as well as other mammalian immunodeficiency viruses, all of which are characterized by their slow 
progression to disease (Freed et al., 2007).  With production of antiretroviral medications (ARVs), this long 
latency period can be exploited to diagnose and treat HIV-1 before it progresses to AIDS.  As of 2012 there 
were 24 Food and Drug Administration approved ARVs that target 5 different viral mechanisms: RT, 
integration, protease cleavage, membrane fusion, and receptor binding (Arts et al, 2012). However, HIV-
1 is a highly mutagenic virus with the capacity to develop resistance to many different ARVs.  Therefore, 
although there are many drugs available, the pressure to find a cure and to combat resistance emphasizes 
the importance for the scientific community to continually identify molecular mechanisms that could 
eventually be used as drug targets. 
One potential target is the RNA genome itself.  While primarily responsible for carrying the genetic 
material of the virus, the RNA genome also serves to regulate various functions of the viral lifecycle.  Many 
of these regulating elements are located in the highly-structured 5′UTR of the viral RNA.  The TAR and 
polyA stem loops, located at the 5′ end of the 5′UTR, are involved in genomic circularization and minus-
strand transfer during RT (reviewed in Basu et al., 2008).  Additionally, these sequences serve as the 
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transcriptional stimulator for viral RNAs in the integrated proviral DNA (Bannwarth et al., 2005).  
Downstream from these stem loops are the TLE stem loop and the PBS, which play roles in RT regulation 
by serving as the location of primer binding (Mak et al., 1997).  It has also been proposed that the TLE 
facilitates RT by localizing the primer (Jones et al., 2013; Jones & Cantara et al., 2014).  At the very 3′ end 
of the 5′UTR are the Psi stem loops which participate in viral packaging and genomic dimerization (Lu et 
al., 2011; Skripkin et al., 1994).  The concentration and diversity of functional elements in this highly-
conserved segment of the HIV-1 viral RNA makes the 5′UTR an ideal candidate for further scientific study.   
Our primary interest with the 5′UTR is the localization of the tRNA primer through the interaction 
between lysyl-tRNA synthetase (LysRS) and the TLE.  As mentioned earlier, many retroviruses hijack host 
cell tRNAs to prime RT and the primer for HIV-1 RT is tRNALys3.  Both tRNALys3 and LysRS are selectively 
packaged into HIV-1 virions, which originally indicated the synthetase’s involvement in selectively-
packaging the tRNA primer (Cen et al., 2001).  Furthermore, other studies have shown that knocking down 
LysRS in cells results in decreased primer incorporation into virions and a less infectious virus (Guo et al, 
2003) whereas overexpression of LysRS had the opposite effect (Guo et al. 2005).  Through analysis of the 
secondary structure of the 5′UTR, it can be seen that the loop of the TLE hairpin has high sequence 
similarity to the anticodon loop of tRNALys3, and contains many of the identity elements for specific 
recognition by LysRS.  Following up on this finding, it was shown that this element clearly mimics tRNALys3 
as it successfully competes with the tRNA for binding with LysRS (Jones et al., 2013).  Furthermore, 
mutation of the UUU in the loop to CCC caused approximately a 40% reduction in viral infectivity (Jones 
et al., 2013).  Molecular envelopes of the PBS/TLE construct and tRNALys3 derived from small-angle X-ray 
scattering (SAXS) were highly homologous, demonstrating that the TLE resembled the tRNA in 3D 
structure as well as sequence (Jones & Cantara et al., 2014).  Finally, it has been demonstrated that LysRS 
binds to the PBS/TLE with the first stem loop of Psi (SL1), better than to the PBS/TLE alone, and addition 
of SL2 improves binding further (Jones et al., 2013).  As neither SL1 or SL2 resemble tRNAs, this trend 
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could suggest that HIV-1 has evolved structures beyond the PBS/TLE domain to facilitate the binding of 
LysRS and the localization of the tRNA primer.  The first section of this chapter will discuss RNA probing of 
the interaction between LysRS and the HIV-1 5′UTR using RNase protection and SHAPE analyzed by CE to 
map the HIV-1 genomic RNA-LysRS interaction.   
We hypothesized that the structure of the HIV-1 5′UTR as a whole will yield insights into its 
function.  Many studies using various techniques have attempted to determine the secondary and tertiary 
structure of the HIV-1 5′UTR.  However, to date no one has solved its complete 3D structure.  The 
secondary structure of the 5′UTR and the rest of the HIV-1 genome has been solved using SHAPE.  
However, the 5′UTR, particularly Psi hairpins, are believed to adopt alternative secondary structures 
depending on the stage in the lifecycle.  Additionally, 3D models have been proposed for large portions 
of the 5′UTR using SAXS and nuclear magnetic resonance spectroscopy (NMR). Along with revealing the 
structural similarities between the HIV-1 PBS/TLE and tRNALys3, the same study modeled the 3D structures 
of two other segments of the HIV-1 5′UTR based on SAXS data: TAR/polyA and Psi (Jones & Cantara et al., 
2014). Furthermore, a larger structure has been solved of the minimal RNA required for genomic RNA 
packaging by NMR.  This RNA consists of the Psi and U5 region of the 5′UTR, deleting the TAR and polyA 
hairpins, and replacing the PBS/TLE and the DIS with GAGA tetraloops (Keane et al., 2015).  The second 
section of this chapter will discuss how SAXS has been used to build upon this NMR structure.  Additionally, 
we will show how a comparison between structures from subgroup A and B imply the conservation of the 
TLE mechanism between these two viral subgroups.   
 
Materials and Methods 
RNA preparation 
 RNA probing experiments were performed with variants of the HIV-1 5’UTR(356), which consists 
of the first 356 nucleotides of the HIV-1 viral RNA.  For preparation of HIV-1 5′UTR(356) constructs, see 
“RNA preparation” in Chapter 1.   
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 All of the RNAs studied by SAXS were variants of the HIV-1 5′UTR ∆TAR/polyA, which will be 
referred to as the HIV-1 5′UTR(240).  Mutations such as extensions and deletions to this construct were 
made to the HIV-1 5′UTR(356) plasmid.  Transcription templates were obtained by PCR from plasmids 
containing the HIV-1 5′UTR(356) sequence.   RNAs were in vitro transcribed and purified in the same 
manner described for other RNAs (see Chapter 1).  RNAs were folded in 50 mM HEPES (pH 7.4) buffer by 
heating to 80°C for 2 min, cooling to 60°C for 2 min, incubating at 37°C for 30 min, and cooling on ice for 
at least 30 min.  The folded RNAs were then purified by size exclusion chromatography, and stored at 4°C 
until ready for analysis.   
Protein preparation 
 Two different constructs of human LysRS were used in this study: LysRS triple mutant (LysRS-3M), 
and LysRS-∆N65.  LysRS-3M is a primarily monomeric construct obtained by substituting three amino acids 
of the dimerization interface (R246, E265, and F283) with alanine residues (Kovaleski et al., 2006).  This 
mutant was incorporated into this study with the hopes of facilitating SAXS studies by alleviating 
oligomerization of LysRS, which leads to sample heterogeneity.  The second construct, LysRS-∆N65, has 
the first 65 N-terminal amino acids deleted.  This is useful as it is known that these 65 residues are 
unstructured, which may lead to conformational heterogeneity, and the deleted residues are not 
necessary for tRNA binding, or aminoacylation (Shiba et al., 1997). It is also the construct that was used in 
most of the in vitro studies characterizing this interaction. 
 Detailed protocols for the purification of LysRS-3M and LysRS-∆N65 can be found in Kovaleski et 
al. (2006) and Jones et al. (2013), respectively.  BL21DE3 cells containing plasmids encoding LysRS-3M and 
LysRS-∆N65 genes were grown in liquid media containing 100 µg/µL ampicillin, and induced by the 
addition of 0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG).  Cells were then lysed using sonication, 
and nucleic acids were precipitated using polyethyleneimine (PEI) precipitation.  The protein was then 
precipitated with ammonium sulfate precipitation, resuspended, and purified using Ni affinity 
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purification.   It was then buffer exchanged into 2X storage buffer (80 mM HEPES, 300 mM NaCl, 4 mM 
DTT), and diluted with 80% glycerol to achieve 40% glycerol final storage solution.  The concentration was 
determined via Bradford assay.  
Small-angle X-ray scattering 
 Size exclusion chromatography (SEC) purified RNAs (Jones & Cantara et al., 2013) were sent to the 
Advanced Light Source beamline 12.3.1 at Lawrence Berkeley National Labs for SAXS data collection.  Data 
were then analyzed using the ATSAS package (Konarev et al., 2006). PRIMUS was used for data 
preprocessing (Konarev et al., 2006) and envelopes were generated using DAMMIN (Konarev et al., 2006). 
Ribonuclease/SHAPE protection assays 
 To probe the interaction between the HIV-1 5′UTR(356) ∆DIS A34U RNA and LysRS-3M, RNase 
protection assays were used.  To probe the interaction between the HIV-1 5′UTR(356) ∆DIS A34U RNA and 
LysRS-∆N65 SHAPE protection assays were used.  These assays consisted of five reactions: background (no 
probing reagent), reaction with probing reagent without protein, and three reactions with probing 
reagent with pre-bound serially diluted protein.  Reactions were initiated with the addition of buffer to 
the background and probing reagent to the other four reactions.  The reactions were incubated for the 
optimized amount of time.  The RNase protection assays were quenched by ethanol precipitating the 
reactions with premixed precipitation/inactivation buffer (Ambion), and the SHAPE protection assays 
were quenched by ethanol precipitating with glycogen.  The reactions were then reverse transcribed by 
annealing NED-labeled primers and following the Superscript III primer extension protocol.  
Sequencing 
 For sequencing information, see “Sequencing” in Chapter 1 
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Results and Discussion 
Section I: LysRS interaction with HIV-1 5′UTR(356) probed by RNases and SHAPE 
  The HIV-1 viral genome is more than 9 thousand nt long, and yet the PBS is only 18 of those 
nucleotides.  Somehow, the tRNA primer needs to be shuttled to the vicinity of the PBS so it can be 
efficiently annealed for RT to initiate.  Logically, this localization would be facilitated by a protein that 
binds to tRNALys3, the primer for HIV-1 RT.  As previously mentioned, LysRS is packaged into HIV-1 virions 
to facilitate primer packaging (Cen et al., 2001), and tRNALys3 can be competed off by the TLE located near 
the PBS in the 5′UTR (Jones et al., 2013).  Additionally, 3D modeling based on SAXS data demonstrated 
that the TLE strongly mimics the three dimensional structure of a tRNA (Jones & Cantara, 2014).  These 
results have led our lab to propose that LysRS is central to the mechanism of localizing the RT primer.  We 
hypothesize that LysRS shuttles the tRNA primer to the PBS/TLE domain of the 5′UTR, after which the 
 
Figure 10:  The proposed mechanism for tRNALys3 localization involves LysRS.  LysRS chaperones the tRNA to the 
5′UTR after which it binds to the TLE, releasing the tRNA in close proximity to the PBS; thus, facilitating primer 
annealing via localization.  The SAXS-derived models below are of the PBS/TLE RNA with (right) and without (left) 
an 18 nt primer annealed (Jones & Cantara et al., 2014).  (Figure prepared by William Cantara.) 
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tRNA is competed off by the TLE, localizing the primer for annealing 
prior to RT (Figure 10).  It has also been shown that adding stem 
loops from Psi to the PBS/TLE RNA significantly decreases the Kd 
(Figure 11) (Jones et al., 2013).  This suggests involvement of these 
stem loops in the specificity of LysRS binding, leading to the 
hypothesis that HIV-1 has developed structures beyond tRNA 
mimicry to enhance competitive binding with tRNALys3 for LysRS.  
This section will explore how RNA probing is being used to interrogate the interaction between LysRS and 
the HIV-1 genome, and inform this hypothesis. 
 The first probing technique employed to investigate this interaction was RNase digestion with 
RNases T1 and V1 analyzed by CE.  Qualitative analysis of these data suggested that LysRS-3M was binding 
to the TLE and to SL1 and SL2 of the HIV-1 5′UTR ∆DIS A34U RNA (Figure 12).  Unfortunately, it was found 
that there was strong signal overlap between channels of the same capillary rendering quantitative 
analysis with the new method described in Chapter 1 impossible.  Prior to completion of the analysis tool, 
the amount of primer extension product optimal for analysis had not been determined, so signal overlap 
was the result of overloading the capillary with sample. These experiments will be repeated using new, 
optimized conditions with the newly-developed quantitative analysis methods. 
 As mentioned in Chapter 1, SHAPE is also being optimized for experiments on the HIV-1 5′UTR.  
However, for both structure probing and protein protection experiments the same road block has been 
preventing progress.  That is, large peaks in the minus traces indicative of low processivity of reverse 
transcriptase is resulting in unanalyzable data.  There are two likely issues that could be causing reverse 
transcriptase to fall off, and both are in the process of being tested.  The first is the simple explanation: 
RNA degradation.  Degraded fragments of RNA at varying lengths would make it appear as if reverse 
transcriptase were falling off prematurely, when in actuality, the polymerase ran out of template at the 
 
Figure 11: Kd values of LysRS-∆N65 
with PBS/TLE and tRNALys3 are very 
similar.  However, as the construct 
is extended to include stem loops 
of the Psi region the Kd values drop 
approximately four-fold (Jones et 
al., 2013). 
 
RNA hLysRS dN65 Kd
tRNALys3 407  33
PBS-TLE 383  18
PBS + Psi SL1 281  25
PBS + Psi SL1, SL2 85.4  5.4
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end of a degraded fragment.  Alternatively, the HIV-1 5′UTR is more highly structured than most RNAs, so 
it is possible that the thermal denaturing cycle used prior to primer extension reactions may not fully 
denature the RNA.  In this case, secondary and tertiary structural elements could be interfering with 
polymerase processivity.  To overcome this, fresh RNA is being prepared and alternative thermal 
denaturing conditions will be tested.    
  
 
Figure 12: RNase V1 and T1 data plotted onto part of the secondary structures of the HIV-1 5′UTR ∆DIS A34U.  
Decrease in peak area can be clearly seen in the images of the electropherograms shown of the TLE and SL1 as 
LysRS is titrated in.  However, this data has not been quantitatively analyzed.   
 
RNase V1 Protection RNase T1 Protection
1
2
1 2
tRNA-like Element Psi Stem Loop 1
32 
 
Section II: SAXS study of HIV-1 5′UTR ∆TAR/polyA  
 The 5′UTR of HIV-1 is a highly-conserved, heavily-structured RNA that is involved in many 
functions of the retroviral lifecycle.  Although many studies have proposed models and structures of small 
pieces of the 5′UTR, no one has reported a structure or model of it in its entirety.  Our lab alone has 
proposed 3D models based on SAXS data of the TAR/polyA stem loops, the Psi stem loops, and the PBS/TLE 
region with and without primer annealed (Jones & Cantara et. al., 2014).  These structures also served to 
reveal the 3D similarities between the TLE and tRNALys3 (Jones & Cantara et. al., 2014).  In this section, a 
recent NMR structure of the HIV-1 minimal packaging element will be discussed. It is currently the largest 
RNA structure to be experimentally determined by NMR (Keane et al., 2015).  In this section, the use of 
SAXS to expand on this structural ground work, and attempts to model even larger constructs of the 5′UTR 
will also be discussed.   
 The goal of SAXS is to generate electron pair-distance distribution functions (PDDF) from which 
low resolution envelopes of molecules can be calculated. The PDDF is a histogram of all inter-electron 
distances in a molecule. We were able to use this method to calculate the envelope of the 5′UTR(240) 
∆DIS (Figure 14A).  However, the resolution of SAXS is not sufficient for unambiguous assignment of one 
region of the RNA from another within an envelope.  For this reason, a series of extension and deletion 
mutants were made to this RNA construct to attempt to determine how the RNA fits into the envelope 
(Figure 13).  Although many of these mutants resulted in good quality data, due to limitations of the 
DAMMIN algorithm, their 
resulting envelopes did not 
converge to a unique shape.  
The 5′UTR(240) ∆DIS 
∆PBS/TLE (which is very 
similar to the construct 
 
Figure 13: This table includes all of the HIV-1 5’UTR(240) RNA constructs that 
were prepared for this SAXS study, their length in nt, and the person(s) 
primarily responsible for their mutagenesis and preparation. 
 
Name Length (nt) Prepared by:
5’UTR(240) WT 240 J. Hatterschide
5’UTR(240) ∆DIS 235 J. Hatterschide/W. Cantara
5’UTR(240) ∆DIS ∆PBS/TLE 154 J. Hatterschide/W. Cantara
5’UTR(240) ∆DIS TLE extension 255 J. Hatterschide
5’UTR(240) ∆DIS ∆SL1 217 W. Cantara
5’UTR(240) ∆DIS SL1 extension 255 J. Hatterschide/W. Cantara
5’UTR(240) ∆DIS GU120AC 235 J. Hatterschide/W. Cantara
5’UTR(240) ∆DIS U288C G294A 235 J. Hatterschide
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solved by Keane et. al.), was one mutant that yielded a useful envelope (Figure 14A).  When overlaid with 
the envelope of 5′UTR(240) ∆DIS, it can be seen that additional density looks remarkably like a tRNA.  This 
fits with previous data showing the TLE mimics the 3D structure of a tRNA, suggesting that this section of 
the SAXS envelope corresponds to the PBS/TLE region (Figure 14B).  However, in order to assign the lobes 
more rigorously, models of the ∆DIS and extension and deletion constructs are currently being generated 
(W. Cantara, unpublished data).  From these, theoretical PDDFs can be calculated and compared to the 
experimental data.   However, the modeling required for an RNA of this size will be time-consuming and 
new methods will need to be developed in order to yield reliable models.  
 Using preliminary helix assignments, it was possible to analyze the model of the UTR(240) ∆DIS in 
comparison to the structure determined by Keane et al.  It was found that our envelope of this very similar 
construct agrees with the NMR model in terms of helical dimensions.  However, the interhelical 
orientations of the NMR structure are very different from those in the SAXS envelope.  When the U5-AUG 
duplex, and the PBS/TLE hairpin of the all atom NMR model are aligned with the corresponding portions 
of the SAXS envelope, the SL1 and SL3 hairpins of the model cannot align with other sections of the 
 
Figure 14: (A) The envelope of the 5′UTR(240) ∆DIS can be seen in the black mesh with the envelope from the 
5′UTR(240) ∆DIS ∆PBS/TLE overlaid in red.  The secondary structure of the UTR(240) ∆DIS and UTR(240) ∆DIS 
∆PBS/TLE can be seen in to the right.  The UTR(240) ∆DIS ∆PBS/TLE is the previous construct with the region in 
the red-dashed box mutated to a GAGA tetraloop.  (C) The extra space remaining in the UTR(240) ∆DIS envelope, 
green-dashed box, resembles the L-shape of a tRNA which is the shape that the TLE has been established to 
adopt.  This gives us a working model of the identities of each lobe of the envelope.  (Figure modified from William 
Cantara)  
 
HIV-1 5’UTR(240)
HIV-1 5’UTR(240) 
∆PBS/TLE
(A)
(B)
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envelope (Figure 15A).  Moreover, when SL1 and SL3 are aligned with their predicted lobes of the SAXS 
envelope, PBS/TLE and U5-AUG do not match the envelope (Figure 15B).  Since the NMR study did not 
employ a method for determining global interhelical angles, it is possible that the interhelical orientations 
of the Keane et al. model could be incorrect.  Alternatively, the inclusion of the large polyanionic PBS/TLE 
domain may alter the interhelical conformation. The SAXS-based modeling should be able to 
unambiguously distinguish the overall global topology resulting in correct determination of interhelical 
orientations. 
 So far, the discussion has been about the 5′UTR(240) that originates from the sequence of the 
5′UTR of the NL4-3 isolate.  HIV-1 NL4-3 is a circulating recombinant form with a 5’UTR corresponding to 
group M, subgroup B, the primary subgroup of HIV-1 that affects Europe, the Americas, and Oceania 
(Hemelaar et al., 2006).  However, if the structures and mechanisms that are discovered in the NL4-3 
isolate are not conserved among many different subgroups of the virus, then they will likely not contribute 
to the understanding of important facets of the HIV-1 lifecycle.  The SAXS-based envelopes of a region 
similar to the UTR(240) in the MAL isolate’s 5′UTR have been calculated (W. Cantara, unpublished data).  
The MAL isolate is a circulating recombinant form, the 5′UTR of which corresponds to group M, subgroup 
 
Figure 15: The UTR(240) ∆DIS envelope has similar volume and dimensions to the Keane el al. model.  The 
predicted lobes of the SAXS envelope are labeled in black, and the helices of the model are color coded: yellow 
is the U5-AUG, red is the PBS/TLE truncated hairpin, green is SL1, and purple is SL3.  (A) The UTR(240) ∆DIS SAXS 
envelope aligned with the Keane et al. all atom model envelope by the U5-AUG duplex and the PBS/TLE, cannot 
accommodate SL1 and SL3 of the model.  (B) The same problem is encountered when the model and the envelope 
are aligned by the other two helices.  (Figure modified from William Cantara). 
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A (Gao et al., 1998), a subgroup that primarily affects western, central, and eastern Africa, eastern Europe, 
and central Asia. (Hemelaar et al., 2006).  Interestingly, the sequence of MAL contains a 23-nucleotide 
insertion that alters the secondary structure of this region of the 5′UTR (Goldschmidt et al., 2004). When 
the NL4-3 and MAL SAXS envelopes are overlaid, it can be seen that despite the differences in sequence 
and secondary structure, the 3D structures of these two large RNAs are very similar (Figure 16).  This 
conservation in 3D structure implies that many of the mechanisms studied with NL4-3 RNAs will be 
conserved in MAL and possibly other subgroups as well.  Finally, the 3D similarities between these two 
RNAs explain how LysRS also selectively binds to the PBS/TLE domain of MAL.  
 Although an all-atom model has not been modeled for the HIV-1 NL4-3 5′UTR(240) ∆DIS, this data 
has been immensely useful in comparison to other data sets.  Not only has it informed our perception of 
 
Figure 16: The overlaid NL4-3 and MAL SAXS envelopes display very high structural similarity despite the relatively 
significant differences in sequence.  This structural similarity implies that many of the structural and functional 
studies perform on the NL4-3 isolate’s 5′UTR can be translated to the MAL isolate.  (Figure modified from William 
Cantara). 
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this complex RNA 3D structure, but it has also contributed to the understanding of more detailed 
structures such as that of Keane et al.  It has also helped to suggest that the 3D structure of the 5′UTR is 
a feature that is conserved between subgroups of HIV-1. 
 
Conclusions and Future Directions 
  
Despite initial progress, RNA probing experiments with the HIV-1 5’ UTR and LysRS are still in the 
process of being optimized.  Direct binding data suggests that the addition of the Psi stem loops SL1 and 
SL2 enhance LysRS binding (Jones et al., 2013).  Initial CE traces have been analyzed qualitatively and 
suggest that LysRS is binding to both the TLE and the first two Psi stem loops—in agreement with the 
direct binding data.  However, once optimization is complete, experiments can be analyzed quantitatively 
to provide a more detailed characterization of the interaction between LysRS and the viral genome.  These 
experiments will help to inform the hypothesis that HIV-1 could have evolved more extensive structures 
than just tRNA mimicry to compete with the tRNA for LysRS binding.  
               The envelope of the HIV-1 5’UTR(240) ∆DIS has been modeled based on SAXS data. This has been 
very useful in comparisons with other envelopes and models.  When the SAXS envelope of the 5’UTR(240) 
∆DIS and 5’UTR(240) ∆DIS ∆PBS/TLE are overlaid we notice that the remaining density has the L-shaped 
structure of a tRNA.  This suggests that the 3D tRNA mimicry that was described in Jones & Cantara et al. 
is conserved in the context of this larger RNA.  The 5’UTR(240) ∆DIS envelope was also able to reveal that 
the inter-helical orientation of the Keane et al. NMR structure is likely incorrect.  Finally, we saw that the 
3D structure of the PBS/TLS and Psi regions of the 5’UTR is conserved between subgroup A and B through 
comparison between the NL4-3 5’UTR(240) and the corresponding region of the 5’UTR from the MAL 
isolate.  An all-atom model will be generated in the future. It should be noted that a model of the HIV-1 
5’UTR(240) ∆DIS would be one of the largest experimentally informed models of the HIV-1 5’UTR and will 
require development of new methods.   
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               The 5’UTR is a very complex RNA, but its involvement in a wide array of viral lifecycle events 
makes it a primary target for further scientific investigation.  Both the RNA probing and SAXS experiments 
will contribute to a more complete understanding of the structure and function of the HIV-1 5’UTR, and 
provide the basis for future studies. 
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Chapter 3: Human T-cell Leukemia Virus Type I 
Introduction 
HTLV-1 is a delta-retrovirus known to be associated with multiple different diseases that are found 
in a small fraction of infected individuals.  The most common and severe of these diseases are adult T-cell 
leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TPS), 
but less common diseases include HTLV-1-associated dermatitis, ocular lesions, and inflammatory 
arthropathy and polymyositis (Lairmore et al., 2012).  ATL, which occurs in about 3-5% of infected 
individuals after a prolonged latency period (reviewed in Fujii et al., 2007), is a highly aggressive form of 
non-Hodgkin’s lymphoma which is clinically identified by clonally expanding CD4+ CD25+ T-cells (Cook et 
al. 2012).  HAM/TSP affects from 0.1 to 2% of individuals infected with HTLV-1, and is characterized by the 
invasion of the cerebrospinal fluid with CD4+ and CD8+ T-cells, damaging the spinal cord and resulting in 
spasticity in the lower half of the body (Osame, 2002; Irish et al., 2009).   
The transmission of HTLV-1 is similar to that of HIV-1 and other retroviruses, but the efficiencies 
of each mode of transmission differ (Biggar et al., 2006; Goncolves et al. 2010). HTLV-1 is not a global 
pandemic like HIV-1, but rather is highly endemic to a few large areas including the Caribbean, Japan, and 
West and Central Africa.  Although these regions of Africa (primarily Nigeria and the Democratic Republic 
of the Congo) are estimated to be the most endemic with HTLV-1, comparatively few large population 
studies have been undertaken in these areas which could affect global approximations of the number of 
HTLV-1 carriers (Gessain et al., 2012).  With this in mind, the most recent epidemiological models of HTLV-
1 infection predict that there are between 5 and 20 million people infected worldwide (De Thé et al., 1993; 
Gessain et al., 2012).  
Attempts to control and treat ATL and HAM/TSP have been met with limited success (Goncolves 
et al., 2010) and there is no cure for either of these diseases.  One of the only treatments found to result 
in a high remission rate among chronic ATL patients (other ATL types not tested) is a combination of 
arsenic trioxide, zidovudine (AZT), and interferon alpha (Kchour et al., 2009).  Clinical studies testing the 
39 
 
efficacy of AZT and interferon alpha on more aggressive types of ATL have been met with more moderate 
remission rates, and all patients eventually relapsed (Matutes et al., 2001).  Furthermore, treatment with 
corticosteroids, interferon alpha, and interferon beta1a have been the only regimens with moderate 
success in treating HAM/TSP (Goncalves et al., 2010).  It has been shown that high proviral load is a 
precursor to ATL progression (Akbarin et al., 2013), suggesting that treatments resulting in lower proviral 
load could be useful in preventing HTLV-1 progression ATL.  This justifies exploring the HTLV-1 lifecycle 
through basic scientific research to uncover more virus-specific target mechanisms.  
As discussed previously, one potential drug target could be the viral mechanisms of primer 
packaging and localization.  HTLV-1 requires the 3′ end of tRNAPro to prime RT, but currently the 
mechanism of packaging is still unknown (Seiki et al., 1982).  However, it is known that other complex 
retroviruses such as HIV-1 and Rous sarcoma virus (RSV) package aminoacyl-tRNA synthetases specific to 
their tRNAs, while simple retroviruses such as Molony murine leukemia virus do not (Cen et al., 2002).  As 
HTLV-1 is also a complex retrovirus, it is possible that it packages glutamyl-prolyl-tRNA synthetase (EPRS) 
in a similar manner.  A recent model produced by our lab of the HTLV-1 5′UTR secondary structure based 
on SHAPE data revealed a stem loop that resembles the anticodon stem loop of tRNAPro.  Much like HIV-
1, this putative TLE lies just 5′ to the PBS, suggesting that EPRS may be involved in the packaging of the 
HTLV-1 primer.  On the other hand, a recent study has demonstrated that HTLV-1 infection stimulates the 
production of a 3′ fragment of tRNAPro, and that HTLV-1 packages both tRNAPro and the fragment into 
virions (Ruggero et al., 2014).  They suggest that this fragment could be the primer for RT along with or in 
place of the full-length tRNA.  Although this in itself does not discount the involvement of EPRS, it does 
suggest that there may be an alternate route of packaging primer RNAs as EPRS would likely not 
specifically recognize the tRNA fragment.  The primary aim of this chapter is to investigate the possible 
interaction between prolyl-tRNA synthetase (ProRS), the tRNAPro charging domain of EPRS, and the HTLV-
1 genome. 
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Materials and Methods 
RNA Preparation 
 Seven different RNA constructs were used in these studies: human tRNAPro, HTLV-1 5′UTR, HTLV-
1 µTLE, HTLV-1 TLE, HTLV-1 R, HTLV-1 U5-5′gag, and HTLV-1 5′gag.  The unmodified human tRNAPro UGG 
construct was used.  The HTLV-1 5′UTR RNA consists of the first 633 nucleotides (nt) of the HTLV-1 viral 
RNA with a 15-nt 5′ linker added.  The HTLV-1 µTLE consists of the 19-nt TLE stem loop with the C-G base 
pair at the bottom of the stem mutated to G-C to improve transcription with T7 RNA polymerase.  The 
HTLV-1 TLE is a 147-nt RNA that consists of the TLE stem loop and the surrounding structure.  The HTLV-1 
R, U5-5′gag, and 5′gag RNAs are fragments of the HTLV-1 5′UTR, each with the 15-nt 5′ linker as well.  R 
corresponds to the 5′ terminal repeat sequence. U5-5′gag consists of the sequence between the beginning 
of the unique 5′ region and the beginning of the gag coding region.  This includes the entire TLE region 
and the PBS.  Finally, the 5′gag sequence consists of the first 175-nt of the gag coding region.   
To prepare the HTLV-1 µTLE RNA, single-stranded template oligomers with the T7 polymerase 
promoter and the RNA coding sequence were ordered from IDT.  The sense and anti-sense oligomers were 
then annealed by heating to 80°C, cooling to 60°C, and cooling on ice.  The µTLE RNA was in vitro 
transcribed from this double stranded template.  The HTLV-1 5′UTR construct is contained in a pUC19 
plasmid, and the transcription template can be obtained by restriction digest with BstYI (W. Cantara & W. 
Wu, unpublished data).  The TLE, R, U5-5′gag, and 5′gag RNAs were cloned out of the full 5′UTR plasmid 
into pUC19 vectors behind T7 promoters (U5-5’gag, and 5’gag cloning performed by W. Cantara & W. 
Wu). The TLE vector was then digested with PstI, and the other three were digested with BstYI to obtain 
their transcription templates.   
After in vitro transcription with T7 RNA polymerase, RNAs were gel purified via denaturing PAGE 
(8M urea).  Excised bands were then crushed and incubated in RNA elution buffer (0.5 mM NH4OAc, 1 mM 
EDTA) at 37°C overnight.  Solutions were then butanol extracted and ethanol precipitated yielding pure 
RNA.   RNAs were then quantified using UV-vis spectrometry.  Extinction coefficients at 260 nm for HTLV-
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1 RNAs are as follows: µTLE, 1.320 X 105 M-1 cm-1; TLE, 1.328 X 106 M-1 cm-1; R, 2.085 X 106 M-1 cm-1; U5-
5’gag, 2.160 X 106 M-1 cm-1; 5’gag, 1.730 X 106 M-1 cm-1. 
Internally 32P-labeled RNAs were in vitro transcribed with the same templates as unlabeled 
constructs in the presence of [α32P] ATP.  They were then purified as described for unlabeled RNAs and 
quantified using scintillation counting.  
Protein Preparation 
 Human ProRS is the tRNAPro charging domain of the multifunctional fusion protein EPRS, and is 
the primary construct used in this study.  This construct was cloned from the EPRS sequence into a pKS509 
vector, and transformed into BL21(DE3) cells as described in Heacock et al. (1996).  Cultures were grown 
in media with 100 µg/µL ampicillin, and induced with 1 mM IPTG to overexpress ProRS. Recovered cells 
were lysed by sonication, and nucleic acids were precipitated with 5 mg/mL protamine sulfate.  ProRS was 
then purified by Ni2+ affinity chromatography as described in Heacock et al. (1996).  Protein elution 
fractions were then buffer exchanged into 2X storage buffer (50 mM HEPES pH 7.4, 300 mM NaCl, 2 mM 
β-mercaptoethanol) and diluted in 80% glycerol to achieve a final 40% glycerol storage solution.  
Concentration was determined by Bradford assay. LysRS-∆N65 was purified as stated in Chapter 2 under 
“Protein purification.” 
Electrophoretic mobility shift assay 
 Electrophoretic mobility shift assays (EMSA) were employed to investigate ProRS binding to the 
HTLV-1 5′UTR.  Internally 32P-labeled HTLV-1 5′UTR RNA was folded in 50 mM HEPES (pH 7.4) buffer by 
heating to 80°C for 2 min, cooling to 60°C for 2 min, adding 10 mM MgCl2, incubating at 37°C for 30 min, 
and cooling on ice for 30 min.  The folded RNAs were then incubated with serially diluted protein 
(concentrations ranging from 0 to 10 µM) at room temperature for 30 min.  The proteins assayed were 
ProRS and LysRS-∆N65.  The reactions were run on native (1 mM MgCl2) PAGE at 4°C and analyzed by 
phosphorimaging.   
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Fluorescent RNA labeling 
 Vicinal hydroxyl groups exclusive to the 3′ terminus of RNAs (2.5 pmols) were oxidized with 1.5 
mM sodium periodate in 100 mM sodium acetate (pH 5.1) solution resulting in two 3′ terminal aldehydes 
(Jones et al., 2013).  These reactions were ethanol precipitated after 1.5 hours.  The resuspended RNAs 
were then 3′ end-labeled with fluorescein-5-thiosemicarbozide (FTSC) by incubation with ten-fold excess 
FTSC in 100 mM sodium acetate buffer at 4°C overnight (Jones et al., 2013).  There free dye was then 
removed with G-25 Roche spin columns, and the RNAs were assessed for purity using urea PAGE.  Labeling 
efficiencies were determined by UV-vis spectrometry (FTSC ε495=85000M-1cm-1). 
Fluorescent Protein Labeling 
 Human ProRS was labeled with fluorescein isothiocyanate (FITC) by incubating 100 µM ProRS with 
1 mM FITC at 4°C overnight.  The free dye was removed by buffer exchanging with 2X ProRS storage buffer 
using 10 kDa MW cutoff centrifugal filters (Amicon).  Solution was assessed for purity by SDS-PAGE.  The 
labeling efficiencies were determined by UV-vis spectrometry (FITC ε495=73000M-1cm-1) 
Fluorescence anisotropy direct binding assay 
 For fluorescence anisotropy (FA) binding , FTSC-labeled RNAs were folded in 50 mM HEPES pH 7.4 
by heating to 80°C for 2 min, cooling to 60°C for 2 min, adding 1 mM MgCl2, incubating at 37°C for 30 min 
(if the RNA is longer than 150 nt), and cooling on ice for 30 min.  RNAs (10 nM) were then incubated with 
serially diluted ProRS at room temperature for 30 min in FA binding buffer (20 mM Tris pH 8, 15 mM NaCl, 
35 mM KCl, 1 mM MgCl2) prior to FA measurement.  Data were plotted and curves were fit to the Hill 
equation.  
 
Results and Discussion 
 Unlike HIV-1, the packaging of the HTLV-1 RT primer has not been well characterized.  In fact, the 
sum of the data concerning the HTLV-1 tRNAPro primer can be found in just two studies.  The first study 
reported a putative PBS to be the reverse complement of the 3′ end of tRNAPro (Seiki et. al., 1982).  The 
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second study showed that HTLV-1 infection stimulates the production of a 3′ fragment of tRNAPro, and 
that this fragment is capable of priming RT and is packaged into virions (Ruggero et. al., 2013). 
Furthermore, this study showed that the full-length tRNAPro is packaged into virions as well.  (Ruggero et. 
al., 2013).  Therefore, to date the only information known about HTLV-1 RT priming is that at least the 3′ 
end of tRNAPro is required, and that multiple potential primers are packaged into virions.  Nothing is known 
about how these primer RNAs are packaged or localized.   
 Recently, our lab proposed a preliminary secondary structure of the HTLV-1 5′UTR solved with 
multiple SHAPE reagents (Figure 17A, W. Wu, unpublished data).  From this structure, a hairpin was 
identified that has high sequence homology to the tRNAPro anticodon stem loop—this hairpin will be 
 
Figure 17: (A) The HTLV-1 5′UTR predicted secondary structure based on SHAPE.  Red circles indicate high reactivity 
with 1M6 (>0.8), yellow circles indicate moderate reactivity (>0.4), and residues in grey text indicate areas with no 
reactivity data.   (B) The hairpin in the black dashed box is the putative TLE, and the circles in green indicate the 
residues that are shared between it and the tRNAPro anticodon stem loop consensus sequence. 
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referred to as the putative TLE.  The putative TLE contains one of the tRNAPro anticodon sequences CGG 
at the center of a 7-nt loop that also contains a uridine residue in the correct position to form a canonical 
tRNA U-turn structure (Figure 17B).  Additionally, this putative TLE is located just 5′ to the PBS, which 
would make it optimal for primer localization. It also resembles the arrangement of functional elements 
in the HIV-1 5′UTR. Sequence analysis shows that the putative TLE is highly-conserved with three sequence 
variants accounting for 93% of all sequences, and only about 5% of sequences contain any kind of 
mutation that could inhibit this hairpin’s function as a TLE (Figure 18).  Multiple complex retroviruses 
package the aminoacyl-tRNA synthetase that binds to their tRNA primer, presumably to facilitate 
packaging of the primer (Cen et. al., 2002).  As mentioned earlier, it has also been show that HIV-1 uses a 
TLE to facilitate primer localization (Jones et. al., 2013; Jones & Cantara et. al., 2014).  Although it is not 
known whether HTLV-1 packages EPRS to facilitate tRNAPro primer packaging, the existence of this putative 
TLE led to the hypothesis that HTLV-1 employs tRNA mimicry analogous to HIV-1 to localize tRNAPro to the 
 
Figure 18: The putative HTLV-1 TLE is shown to be highly conserved when compared to 320 HTLV-1 LTR 
sequences from different groups and subgroups. These tables list every mutation found in the 17-nt stem and 
loop of the putative TLE.  The vast majority of sequences are identical to the one used in in vitro experiments, 
and only 5.3% of sequences contain mutations that would negatively Impact the functionality of a TLE.  
Furthermore, only three individual nucleotides in the hairpin are less than 98% conserved: G341, U342, and 
C357.  However, the majority of mutations at these nucleotides are compensatory mutations. 
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PBS.  To test this hypothesis, various binding experiments were performed to test the interaction between 
ProRS and various RNA constructs of the HIV-1 genome. 
 Electrophoretic mobility shift assays (EMSAs) were used to assay ProRS binding to the full length 
HTLV-1 5′UTR.  To control for specificity to ProRS, LysRS-∆N65 was assayed in parallel. However, Kd values 
could not be calculated due to consistent RNA aggregation in the wells at higher concentrations of both 
proteins.  Therefore, these assays were inconclusive.  It is possible that this assay failed because the 
protein:RNA complex was too large to fit into the matrix of the gel.  Alternatively, these RNA binding 
proteins could be causing this large RNA to aggregate.   
 The next binding scheme that was attempted was to titrate fluorescently-labeled protein with 
various RNA constructs including tRNAPro, and HTLV-1 R, U5-5′gag, and 5′gag.  However, even at very high 
concentrations of RNA no change in anisotropy was observed.  There are a few reasons that could explain 
the failure of this binding scheme.  The first is that large globular proteins typically exhibit fairly high 
anisotropy in solution without ligand bound.  This could make the change in anisotropy upon ligand 
binding imperceptible.  This has not been ruled out, but it should be noted that the baseline anisotropy 
values that fluorescently labeled ProRS exhibited were not dissimilar to those exhibited by free tRNA in 
solution.  Another potential explanation of these results lies in the nature of ProRS.  As a class II tRNA 
synthetase, ProRS is functional as a dimer.  Therefore, the low assay concentrations may be too far below 
the dimerization constant, and it may not efficiently bind to RNA.  The final possible explanation comes 
from the process used to fluorescently label the protein.   The isothiocyanate component of FITC is 
intended to react with free amine groups of proteins.  However, amines from amino acids such as lysine 
can be important for interaction with nucleic acids in many proteins, so it is possible that the chemical 
labeling of ProRS is interfering with RNA binding.   
 The final binding scheme, and the only successful one, involved titrating fluorescently-labeled 
RNA constructs with ProRS.  Although very high concentrations of the protein were needed to get 
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saturated binding curves (including for the tRNA), Kd values were able to be calculated for multiple 
constructs using this method: tRNAPro, µTLE, TLE, and U5-5′gag.  The Hill equation was used to fit these 
plots, and calculate Kd and n values.  It was found that ProRS binds consistently to RNAs containing the 
putative TLE with two-fold higher Kd values than to tRNAPro [p-values <0.01] (Figure 19).  This suggests that 
ProRS is not binding specifically to the putative TLE.  This low specificity implies that the putative TLE 
would be unable to compete with the tRNA for binding to ProRS, making this hairpin a poor primer-
localizing device.  A negative control still needs to be completed to confirm this result, however 
preliminary experiments suggest the binding will be similar to that of RNAs containing the TLE.      
 There are a few obvious limitations to these experiments.  First, it is possible that ProRS binds to 
the putative TLE more specifically in the context of other regions of the 5′UTR that are not included in any 
of these constructs.  Second, ProRS is naturally a part of the bifunctional fusion protein, EPRS, and other 
regions of this protein that are not included in this ProRS construct could affect this domain’s ability to 
bind RNA, and its specificity towards RNAs.  Finally, it is possible that this hairpin is not functioning as a 
TLE in a manner similar to that of the HIV-1 TLE.   
 
Figure 19:  FA assays with titrated ProRS show that ProRS binds approximately two-fold tighter to tRNAPro than to 
putative TLE containing RNAs.  This suggests that the putative TLE would not bind to ProRS efficiently enough to 
compete with tRNAPro, rendering this hairpin ineffective for primer localization. 
 
µTLE
TLE
U5-5’gag
RNA ProRS Kd (µM) n
tRNAPro 2.30 0.20 2.6  0.1 
µTLE 5.29 0.36 2.7  0.3
TLE 4.32 0.29 2.0  0.2
U5-5’gag 4.59 0.62 1.6  0.3
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Conclusions and Future Directions 
 These results suggest that the putative TLE hairpin is not mimicking tRNAPro, and do not support 
the original hypothesis that the function of this hairpin is to localize the RT primer.  This leaves us with the 
open questions: (1) In the absence of a TLE how does HTLV-1 localize its RT primer? and (2) What function 
does this highly-conserved hairpin serve?  There are a few alternative hypotheses that still need to be 
explored to fully eliminate the possibility of this hairpin’s involvement in tRNA localization.  First, the ProRS 
domain may not reflect of the binding specificity of EPRS.  Conversely, EPRS may not be the only protein 
that binds specifically to tRNAPro.  It is also possible that the conservation of this hairpin is due to its 
involvement in a completely different function such as binding to Gag during genomic RNA packaging.  
Therefore, to further understand the mechanism of primer localization and other functions of HTLV-1 
RNAs, additional studies need to be performed to survey the proteins that bind specifically to tRNAPro, and 
to the HTLV-1 genomic RNA. 
 Finally, to better understand the mechanism of RT primer packaging, in vivo experiments need to 
be performed to determine whether EPRS is involved in the life cycle of HTLV-1.  To date, it remains 
unknown whether EPRS is packaged into HTLV-1 virions.  Therefore, even if EPRS is not involved in primer 
localization, it still may be involved in primer packaging, similar to the proposed function of synthetases 
in HIV-1 and RSV (Cen et al., 2002).  Alternatively, EPRS is a key factor in the formation of the interferon-
gamma-activated inhibitor of translation (GAIT) complex, which functions to silence the translation of 
transcripts containing GAIT elements (Sampath et al., 2004).  Furthermore, HIV-1 infection results in the 
down regulation of EPRS (Mohammadi et al., 2013) and it is hypothesized that this functions to minimize 
GAIT complex silencing of HIV-1 translation.  It is not clear whether HTLV-1 has this same effect on EPRS.  
However, if this down regulation is shared between these viruses, this could explain why HTLV-1 would 
employ an alternative primer-localization mechanism that does not involve EPRS.  Future experiments will 
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contribute to a better understanding of these lifecycle mechanisms that are crucial to a retrovirus such as 
HTLV-1.   
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Conclusion 
HIV-1 and HTLV-1 are deadly viruses and the only two retroviruses known to cause human disease.  
HIV-1, the known cause of AIDS, is a global pandemic infecting 37 million people (World Health 
Organization, 2015), while HTLV-1 infects from 5-20 million people and causes ATL, HAM/TSP, and other 
associated diseases in a fraction of the infected population.  This emphasizes the importance of studying 
these viruses with the hope of gaining knowledge that can eventually be translated into treating these 
patients.  In this thesis, studies in both viruses focused on the functionally-dense and highly-conserved 
5′UTR of the viral genomic RNA were performed. 
To understand the structure of a large RNA, the first step is to experimentally determine the 
secondary structure using various RNA probing methods.  These methods can also be useful for probing 
the functionalities of these RNAs. RNA probing with RNases and SHAPE has been optimized for 
experimentation with several RNA constructs.  Additionally, the analysis method that has been developed 
has built upon existing software, particularly QuShape (Karabiber et al., 2013) and FAST (Pang et al., 2011), 
to create a more accurate and easier-to-use analysis tool.   This approach has allowed us to solve the 
5’UTR secondary structure of HTLV-1.   
One function of the 5′UTR that is of particular interest is that of tRNA localization.  Previous studies 
have demonstrated that knockdown of LysRS in HIV-1 infected cells results in lower viral infectivity (Guo 
et al, 2003) because the synthetase is packaged into virions to facilitate tRNA packaging (Cen et al., 2001).  
LysRS is not only involved in this function of primer packaging, but it has also been established to be 
involved in primer localization to the PBS through interaction with the TLE (Jones et al., 2013; Jones & 
Cantara et al., 2014).  Direct binding data reveals that LysRS binds tighter to the TLE in constructs 
containing two of the Psi stem loops than to the TLE alone (Jones et al., 2013).  RNA probing is being 
employed to probe this interaction.  Qualitatively analyzed RNase probing data suggest that LysRS is 
interacts with SL1 and SL2 of Psi, as well as with the TLE.  
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We are also interested in the overall structure of the 5′UTR of HIV-1.  Previously, SAXS has been 
used to generate models of three individual pieces of the 5′UTR (Jones & Cantara et al., 2014).  
Additionally, a large structure of the minimal packaging signal has also been solved using NMR (Keane et 
al., 2015).  Using SAXS, an envelope of the HIV-1 5′UTR(240) has been generated that includes all of the 
Keane et al. NMR structure plus the PBS/TLE region.  This structure has shown that 3D L-shape of a tRNA 
found in Jones & Cantara et al. is conserved when the TLE is in the context of this larger RNA.  Additionally, 
it was established that the inter-helical orientations of the NMR model in Keane et al. are likely incorrect.  
Finally, when this SAXS envelope is compared to the envelope of a similar region of the MAL isolate’s 
5′UTR, it can be seen that the 3D structure is conserved. 
The process of primer localization has been explored in HIV-1.  However, not much is known about 
this process, or that of primer packaging, in HTLV-1.  It has been shown that HIV-1 and RSV package the 
aminoacyl-tRNA synthetase that matches their tRNA primers into virions (Cen et al., 2002).  Although, 
HTLV-1 is a complex retrovirus like these other two retroviruses, it is not known whether EPRS is involved 
in tRNA packaging.  The recently solved secondary structure of the HTLV-1 5′UTR revealed what appeared 
to be a TLE, and was situated in a similar location relative to the PBS as the TLE is in HIV-1.  Additionally, 
sequence analysis determined that the putative TLE is highly-conserved.  This led to the hypothesis that 
EPRS may be involved in the localization of the HTLV-1 primer.  This hypothesis was tested in vitro using 
direct binding assays to the ProRS domain of EPRS.  It was demonstrated that the putative TLE-containing 
RNAs bound with two-fold higher Kd values to ProRS, suggesting that EPRS may not be involved in the 
localization of the tRNA to the HTLV-1 PBS.  Future studies will address the potential role of other domains 
of EPRS in this binding interaction.  
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